Inventor · disambiguated record
Umesh Muchhal
Also filed as: MUCHHAL UMESH · MUCHHAL UMESH S
26 granted patents·25 pending applications·250 citations·filing 1999–2025
96Inventor score
Top patents by PatentIndex Score
51 records- 0198US10259887B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2016·Granted Apr 16, 2019·25 cites·25 claims
- 0298US9856327B2Heterodimeric antibodies to CD3 X CD123XENCOR INC·Filed 2016·Granted Jan 2, 2018·72 cites·5 claims
- 0397US11472890B2Heterodimeric antibodies that bind ENPP3 and CD3XENCOR INC·Filed 2020·Granted Oct 18, 2022·9 cites·4 claims
- 0497US11225528B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2019·Granted Jan 18, 2022·11 cites·13 claims
- 0597US10526417B2Heterodimeric antibodies that bind CD3 and CD38XENCOR INC·Filed 2015·Granted Jan 7, 2020·27 cites·15 claims
- 0695US9850320B2Heterodimeric antibodies to CD3 X CD20XENCOR INC·Filed 2016·Granted Dec 26, 2017·13 cites·5 claims
- 0794US7244823B2TNF-alpha variants proteins for the treatment of TNF-alpha related disordersXENCOR INC·Filed 2002·Granted Jul 17, 2007·49 cites·36 claims
- 0892US11945880B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2021·Granted Apr 2, 2024·1 cites·13 claims
- 0992US11859011B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2021·Granted Jan 2, 2024·1 cites·2 claims
- 1088US12359002B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2023·Granted Jul 15, 2025·0 cites·2 claims
- 1188US11352442B2Heterodimeric antibodies that bind CD3 and CD38XENCOR INC·Filed 2019·Granted Jun 7, 2022·2 cites·19 claims
- 1288US2025109215A1Heterodimeric antibodies that bind cd3 and tumor antigensXENCOR INC·Filed 2024·Application pending·0 cites
- 1388US2025304724A1Heterodimeric antibodies that bind cd3 and tumor antigensXENCOR INC·Filed 2025·Application pending·0 cites
- 1487US2025109214A1Heterodimeric antibodies that bind cd3 and cd38XENCOR INC·Filed 2024·Application pending·0 cites
- 1586US10889653B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2015·Granted Jan 12, 2021·2 cites·4 claims
- 1685US2025333519A1Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2025·Application pending·0 cites
- 1784US10913803B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2018·Granted Feb 9, 2021·1 cites·11 claims
- 1884US7144987B1Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disordersXENCOR INC·Filed 2003·Granted Dec 5, 2006·23 cites·19 claims
- 1982US10752678B2Complement component C5 antibodiesALLERGAN INC·Filed 2018·Granted Aug 25, 2020·1 cites·20 claims
- 2081US9701743B2Complement component C5 antibodiesALLERGAN INC·Filed 2015·Granted Jul 11, 2017·3 cites·14 claims
- 2181US2023041377A1Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2022·Application pending·0 cites
- 2280US12129309B2Heterodimeric antibodies that bind CD3 and CD38XENCOR INC·Filed 2022·Granted Oct 29, 2024·0 cites·13 claims
- 2380US8394374B2Optimized antibodies that target HM1.24BERNETT MATTHEW J·Filed 2007·Granted Mar 12, 2013·4 cites·11 claims
- 2479US11312770B2Bispecific and monospecific antibodies using novel anti-PD-1 sequencesXENCOR INC·Filed 2018·Granted Apr 26, 2022·1 cites·4 claims
- 2579US9932395B2Nucleic acids encoding complement component C5 antibodiesALLERGAN INC·Filed 2017·Granted Apr 3, 2018·2 cites·2 claims
- 2678US11673972B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2020·Granted Jun 13, 2023·0 cites·7 claims
- 2774US7071307B2Nucleic acids and proteins with thioredoxin reductase activityXENCOR INC·Filed 2002·Granted Jul 4, 2006·3 cites·11 claims
- 2873US11492407B2Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2019·Granted Nov 8, 2022·0 cites·6 claims
- 2973US2024279317A1Complement component c5 antibodiesALLERGAN INC·Filed 2024·Application pending·0 cites
- 3070US11111315B2Heterodimeric antibodies that bind CD3 and tumor antigensXENCOR INC·Filed 2018·Granted Sep 7, 2021·0 cites·11 claims
- 3169US12152076B2Bispecific and monospecific antibodies using novel anti-PD-1 sequencesXENCOR INC·Filed 2022·Granted Nov 26, 2024·0 cites·11 claims
- 3269US2023227581A1Heterodimeric antibodies that bind enpp3 and cd3XENCOR INC·Filed 2022·Application pending·0 cites
- 3367US2021101965A1Complement component c5 antibodiesALLERGAN INC·Filed 2020·Application pending·0 cites
- 3461US2005060767A1DNA shuffling to produce herbicide selective cropsFiled 2003·Application pending·0 cites
- 3560US2025304667A1Complement component c5 antibodiesALLERGAN INC·Filed 2025·Application pending·0 cites
- 3657US2022135684A1Bispecific antibodies that bind pd-l1 and cd28XENCOR INC·Filed 2021·Application pending·0 cites
- 3755US9040042B2Optimized antibodies that target HM1.24BERNETT MATTHEW J·Filed 2013·Granted May 26, 2015·0 cites·20 claims
- 3855US2006253922A1DNA shuffling to produce herbicide selective cropsSUBRAMANIAN VENKITESWARAN·Filed 2006·Application pending·0 cites
- 3955US2006253923A1DNA shuffling to produce herbicide selective cropsSUBRAMANIAN VENKITESWARAN·Filed 2006·Application pending·0 cites
- 4055US2007207961A1TNF-alpha VARIANTS PROTEINS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERSXENCOR INC·Filed 2007·Application pending·0 cites
- 4154US2006228759A1Analysis of MHC-peptide binding interactionsXENCOR INC·Filed 2006·Application pending·0 cites
- 4253US2004137581A1Interferon variants with improved propertiesXENCOR INC·Filed 2003·Application pending·0 cites
- 4353US2005054053A1Interferon variants with improved propertiesXENCOR INC·Filed 2004·Application pending·0 cites
- 4452US2006149482A1Nucleic acids and proteins with thioredoxin reductase activityXENCOR INC·Filed 2005·Application pending·0 cites
- 4548US2008219974A1Optimized antibodies that target hm1.24BERNETT MATTHEW J·Filed 2007·Application pending·0 cites
- 4648US2003211511A1Nucleic acids and proteins with thioredoxin reductase activityFiled 2002·Application pending·0 cites
- 4746US2006228758A1Analysis of MHC-peptide binding interactionsXENCOR INC·Filed 2006·Application pending·0 cites
- 4844US2006084116A1Analysis of MHC-peptide binding interactionsXENCOR INC·Filed 2005·Application pending·0 cites
- 4941US2006242731A1DNA shuffling to produce herbicide selective cropsSUBRAMANIAN VENKITESWARAN·Filed 2006·Application pending·0 cites
- 5040US2018305465A1Heterodimeric antibodies that bind cd3 and cd38AMGEN INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →